시장보고서
상품코드
1808931

세계의 셀룰라이트 치료 시장 : 유형별, 성별, 연령층별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 규모, 점유율, 예측(2025-2032년)

Cellulite Treatment Market, By Treatment Type, By Gender, By Age Group, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 316 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

셀룰라이트 치료 시장 규모는 2024년에 24억 233만 달러로 평가되었고, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 10.11%로 성장할 것으로 예상됩니다.

셀룰라이트 치료 시장은 특히 여성의 미의식 증가와 비침습적인 미용 시술에 대한 수요 증가로 꾸준한 성장을 이루고 있습니다. 좌식 위주의 생활방식, 호르몬 변화, 노화 등의 요인이 특히 여성 인구에서 셀룰라이트의 높은 유병률에 기여하고 있습니다. 레이저 치료 및 고주파와 같은 비침습적 치료는 안전성과 최소한의 다운타임으로 높은 인기를 얻고 있습니다. 또한 소비자가 합리적인 가격의 대체품을 찾고 있기 때문에 가정용 솔루션과 국소 제품도 급증하고 있습니다. 셀룰라이트 치료 시장은 기술 혁신, 광범위한 미의식, 비침습적이고 개별화된 솔루션에 대한 수요가 증가함에 따라 급성장하고 있습니다. 그러나 브랜드와 클리닉은 관심을 지속가능한 성장으로 바꾸기 위해서 특히 신뢰, 합리적인 가격, 규제의 복잡성을 극복하는 등 중요한 과제를 해결해야 합니다.

셀룰라이트 치료 시장 - 시장 역학

비침습적인 미용 치료에 대한 수요 증가

셀룰라이트 치료 시장의 주요 촉진요인 중 하나는 비침습적이고 낮은 침습 미용 시술에 대한 수요 증가입니다. 소비자는 최소한의 불편함, 회복 시간 또는 위험을 최소화하면서 눈에 보이는 결과를 제공하는 치료를 점점 더 추구하고 있습니다. 미국 성형외과학회에 따르면 비침습적인 미용 성형 수술은 지난 5년간 20% 이상 증가하고 있으며, 보다 안전한 외래 치료로의 명확한 시프트를 부각하고 있습니다. 고주파, 레이저 치료, 크라이오 지방 분해와 같은 기술은 비 수술적 특성과 비교적 빠른 결과로 셀룰 라이트 감소를 위해 널리 채택되었습니다. 미국 국립위생연구소(NIH)에 따르면, 최근 조사는 2023년에 성형외과의사가 실시한 외과적 및 비외과적 미용 성형 수술은 3,490만 건으로 전 세계적으로 3.4% 증가하는 것으로 보고되었습니다. 외과적 처치는 세계 1,580만 건 이상, 비외과적 처치는 1,910만 건 이상이었습니다. 특히 25-45세의 여성들 사이에서 몸의 윤곽을 정돈하고 피부를 강화하는 경향이 계속 확대되고 있기 때문에 이러한 솔루션에 대한 수요가 세계적으로 높아지고 있으며, 시장 전체의 성장에 박차를 가하고 있습니다.

셀룰라이트 치료 시장 - 세분화 분석 :

세계 셀룰라이트 치료 시장은 치료 유형, 성별, 연령대, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 치료 유형에 따라 비침습성, 저침습성, 국소성의 세 가지 범주로 나뉩니다. 3가지 치료 유형 중 비침습성 부문은 셀룰라이트 치료 시장을 독점합니다. 이것은 주로 무통 치료, 최소 회복 시간 및 수술 옵션에 비해 낮은 위험 때문입니다. 고주파, 레이저 치료, 초음파 등의 치료는 환자와 시술자에게 널리 선호됩니다. 가동 중지 시간이 없는 클리닉 기반의 신속한 솔루션에 대한 수요가 증가함에 따라 비침습적인 방법은 선진국 시장과 신흥 시장 모두에서 가장 많이 채택된 범주가 되었습니다.

최종 사용자별로는 병원, 피부과 클리닉, 미용 클리닉/메디컬 스파, 가정용 네 가지 범주로 나뉩니다. 4가지 최종 사용자 구분 중 셀룰라이트 치료 시장을 독점하고 있는 것은 미용 클리닉/메디컬 스파입니다. 이 시설은 미용 치료를 전문으로하며 셀룰라이트 감소에 선호되는 고도로 비 침습적인 기술을 갖추고 있습니다. 이 시설은 편안하고 전문적인 환경과 개인에 맞는 치료 계획을 제공하고 신속하고 효과적인 결과를 추구하는 많은 환자를 유치합니다. 병원에 비해 저렴한 가격으로 미용 케어에 중점을두고 있기 때문에 소비자들 사이에서 가장 인기있는 옵션이되고 있습니다.

셀룰라이트 치료 시장 - 지리적 통찰

북미는 셀룰라이트 치료 시장을 선도하고 있으며, 이는 미용 치료에 대한 소비자의 높은 지출, 첨단 메디컬 에스테틱 인프라, 비침습적 치료에 대한 광범위한 인식에 의해 견인되고 있습니다. 미국은 바디 윤곽 형성과 안티 에이징 서비스에 대한 수요가 증가함에 따라 주요 점유율을 차지합니다. 유럽이 이어지면서 독일, 프랑스, 영국 등의 국가들이 미용 기술의 강력한 도입을 보여주고 있습니다. 한편, 아시아태평양은 미의식 증가, 가처분소득 증가, 중국, 한국, 인도 등 국가에서 피부과 서비스에 대한 접근 확대에 힘입어 급속히 상승하고 있습니다. 라틴아메리카와 중동 및 아프리카는 완만한 성장을 보이고 있지만, 도시화의 진전과 외관 향상에 대한 관심이 높아짐에 따라 아직 개발되지 않은 잠재력을 가지고 있습니다.

셀룰라이트 치료 시장 - 경쟁 구도 :

셀룰라이트 치료 시장은 적당히 세분화되고 있으며, 여러 기존 기업과 신규 기업이 비침습적, 저침습적, 국소적인 각 분야에서 경쟁하고 있습니다. 셀룰라이트는 여성의 최대 90%에 영향을 미치며 미국에서는 치료에 연간 10억 달러 이상이 소요됩니다. 이 분야의 주요 기업으로는 Soliton, Inc., Shockwave Medical, Inc., Pfizer Inc., Sesen Bio, Inc., and Boston Scientific Corporation 등이 있습니다. Soliton은 셀룰라이트 감소에 관한 개념 실증 임상시험(“POC 시험”)의 긍정적인 데이터가 확인된 후 셀룰라이트에 대한 매우 중요한 시험을 진행하기로 결정했다고 발표했습니다. 이러한 기업들은 치료 효과와 환자 만족도를 높이기 위해 고주파, 레이저 시스템, 주사액 등의 첨단 기술에 투자하고 있습니다. 전략적 제휴, 제품 출시, 지역 확대는 기업이 시장에서의 존재감을 강화하기 위한 것이기 때문에 일반적입니다. Allergan의 주사 치료, QWO(R), Hologic의 SculpSure(R) 레이저 플랫폼은 시장의 견인 역할을 하는 주목할 만한 혁신입니다. 비수술미용 솔루션에 대한 수요가 증가함에 따라 장비 제조업체와 미용 서비스 제공 업체 간의 경쟁이 치열 해지고 있습니다.

목차

제1장 셀룰라이트 치료 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 셀룰라이트 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 셀룰라이트 치료 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 셀룰라이트 치료 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 셀룰라이트 치료 시장 상황

  • 셀룰라이트 치료 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 셀룰라이트 치료 시장 - 치료 유형별

  • 개요
    • 치료 유형별 부문 점유율 분석
    • 비침습적
    • 저침습
    • 주제

제8장 셀룰라이트 치료 시장 - 성별

  • 개요
    • 성별 부문 점유율 분석
    • 여성
    • 남성

제9장 셀룰라이트 치료 시장 - 연령층별

  • 개요
    • 연령층별 부문 점유율 분석
    • 18-30세
    • 31-45세
    • 46-60세
    • 60세 이상

제10장 셀룰라이트 치료 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 피부과 클리닉
    • 미용 클리닉/메디컬 스파
    • 가정용

제11장 셀룰라이트 치료 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 셀룰라이트 치료 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • AbbVie Inc.(Allergan Aesthetics)
    • Lumenis Ltd.
    • Candela Medical
    • Solta Medical
    • Cynosure LLC
    • BTL Aesthetics
    • Cutera Inc.
    • Merz Pharmaceuticals
    • Endo International plc
    • Venus Concept Inc.
    • 기타

제13장 애널리스트의 전방위적 전망

SHW 25.09.26

Cellulite Treatment Market size was valued at US$ 2,402.33 Million in 2024, expanding at a CAGR of 10.11% from 2025 to 2032.

The cellulite treatment market is experiencing steady growth due to rising aesthetic awareness, especially among women, and the increasing demand for non-invasive cosmetic procedures. Factors such as a sedentary lifestyle, hormonal changes, and aging contribute to the high prevalence of cellulite, particularly in the female population. Non-invasive treatments like laser therapy and radiofrequency are highly popular for their safety and minimal downtime. The market is also seeing a surge in at-home solutions and topical products as consumers seek affordable alternatives. The cellulite treatment market is growing fast, powered by technological innovation, broader aesthetic awareness, and rising demand for non-invasive, personalized solutions. However, brands and clinics must address critical challenges, especially around trust, affordability, and navigating regulatory complexity, to convert interest into sustainable growth.

Cellulite Treatment Market- Market Dynamics

Rising Demand for Non-Invasive Aesthetic Procedures

One of the primary drivers of the cellulite treatment market is the increasing demand for non-invasive and minimally invasive cosmetic procedures. Consumers increasingly seek treatments that offer visible results with minimal discomfort, recovery time, or risk. According to the American Society of Plastic Surgeons, non-invasive cosmetic procedures increased by over 20% in the last five years, highlighting a clear shift toward safer, outpatient treatments. Technologies like radiofrequency, laser therapy, and cryolipolysis are widely adopted for cellulite reduction due to their non-surgical nature and relatively quick results. As per the National Institute of Health (NIH), the latest survey reported a global increase of 3.4%, including 34.9 million surgical and nonsurgical aesthetic procedures performed by plastic surgeons in 2023. More than 15.8 million surgical procedures and more than 19.1 million nonsurgical procedures were performed worldwide. As body contouring and skin-tightening trends continue to grow, particularly among women aged 25-45, the demand for such solutions globally is rising, fueling overall market growth.

Cellulite Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.11% over the forecast period (2025-2032)

Based on Treatment Type segmentation, Non-Invasive was predicted to show maximum market share in the year 2024

Based on age group segmentation, 18-30 years was the leading age group in 2024

Based on end use segmentation, Aesthetic Clinics/Medical Spas was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Cellulite Treatment Market- Segmentation Analysis:

The Global Cellulite Treatment Market is segmented on the basis of Treatment Type, Gender, Age Group, End User, and Region.

The market is divided into three categories based on Treatment Type: Non-Invasive, Minimally Invasive, and Topical. Among the three treatment types, the Non-Invasive segment dominates the cellulite treatment market. This is largely due to its painless procedures, minimal recovery time, and lower risk compared to surgical options. Treatments like radiofrequency, laser therapy, and ultrasound are widely preferred by patients and practitioners alike. The increasing demand for quick, clinic-based solutions without downtime has made non-invasive methods the most adopted category in both developed and emerging markets.

The market is divided into four categories based on end user: Hospitals, Dermatology Clinics, Aesthetic Clinics/Medical Spas, and Home Use. Among the four end-user segments, Aesthetic Clinics/Medical Spas dominate the cellulite treatment market. These facilities specialize in cosmetic procedures and are equipped with advanced, non-invasive technologies preferred for cellulite reduction. They offer a comfortable, professional environment with personalized treatment plans, attracting a large number of patients seeking quick and effective results. Their affordability compared to hospitals and focus on beauty care make them the most popular choice among consumers.

Cellulite Treatment Market- Geographical Insights

North America leads the cellulite treatment market, driven by high consumer spending on cosmetic procedures, advanced medical aesthetics infrastructure, and widespread awareness of non-invasive treatments. The United States holds a major share due to the growing demand for body contouring and anti-aging services. Europe follows closely, with countries like Germany, France, and the UK showing strong adoption of aesthetic technologies. Meanwhile, the Asia-Pacific region is emerging rapidly, fueled by increasing beauty consciousness, rising disposable incomes, and expanding access to dermatology services in countries like China, South Korea, and India. Latin America and the Middle East & Africa show moderate growth but hold untapped potential due to growing urbanization and rising interest in appearance enhancement.

Cellulite Treatment Market- Competitive Landscape:

The cellulite treatment market is moderately fragmented, with several established companies and emerging players competing across non-invasive, minimally invasive, and topical segments. Cellulite affects up to 90% of women and over a billion dollars per year is spent on treatment in the US. Key companies in this space include Soliton, Inc., Shockwave Medical, Inc., Pfizer Inc., Sesen Bio, Inc., and Boston Scientific Corporation. Soliton has announced its decision to move forward with a pivotal trial in cellulite after positive data from its proof of concept clinical trial for the reduction of cellulite (the "POC Trial") confirmed. These companies are investing in advanced technologies like radiofrequency, laser systems, and injectable solutions to enhance treatment efficacy and patient satisfaction. Strategic collaborations, product launches, and regional expansions are common as companies aim to strengthen market presence. Allergan's injectable treatment, QWO(R), and Hologic's SculpSure(R) laser platform are notable innovations gaining market traction. With growing demand for non-surgical cosmetic solutions, competition is intensifying among device manufacturers and aesthetic service providers.

Recent Developments:

In November 2024, Tiger Aesthetics Medical, LLC announced the acquisition of Revelle Aesthetics, Inc., the developer of Aveli, a breakthrough FDA-cleared cellulite reduction device. This acquisition expands Tiger Aesthetics' presence in the fast-growing field of regenerative body aesthetics, complementing its portfolio with advanced solutions for lower body rejuvenation.

In May 2021, Allergan Aesthetics, an AbbVie company, announced the acquisition of Soliton Inc. for approximately $550 million to expand its cellulite treatment portfolio. Soliton's RESONIC Rapid Acoustic Pulse device, FDA-cleared for non-invasive cellulite treatment, showed 92.9% patient satisfaction in clinical trials. The acquisition complements Allergan's existing CoolSculpting Elite offerings. This move strengthens Allergan's position in the aesthetic body contouring market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL CELLULITE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc. (Allergan Aesthetics)
  • Lumenis Ltd.
  • Candela Medical
  • Solta Medical
  • Cynosure LLC
  • BTL Aesthetics
  • Cutera Inc.
  • Merz Pharmaceuticals
  • Endo International plc
  • Venus Concept Inc.
  • Others

GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Invasive
  • Minimally Invasive
  • Topical

GLOBAL CELLULITE TREATMENT MARKET, BY GENDER- MARKET ANALYSIS, 2019 - 2032

  • Female
  • Male

GLOBAL CELLULITE TREATMENT MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

  • 18-30 years
  • 31-45 years
  • 46-60 years
  • Above 60 years

GLOBAL CELLULITE TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics/Medical Spas
  • Home Use

GLOBAL CELLULITE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cellulite Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cellulite Treatment Market Snippet by Treatment Type
    • 2.1.2. Cellulite Treatment Market Snippet by Gender
    • 2.1.3. Cellulite Treatment Market Snippet by Age Group
    • 2.1.4. Cellulite Treatment Market Snippet by End User
    • 2.1.5. Cellulite Treatment Market Snippet by Country
    • 2.1.6. Cellulite Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Cellulite Treatment Key Market Trends

  • 3.1. Cellulite Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cellulite Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cellulite Treatment Market Opportunities
  • 3.4. Cellulite Treatment Market Future Trends

4. Cellulite Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cellulite Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cellulite Treatment Market Landscape

  • 6.1. Cellulite Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cellulite Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 7.1.2. Non-Invasive
    • 7.1.3. Minimally Invasive
    • 7.1.4. Topical

8. Cellulite Treatment Market - By Gender

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Gender, 2024 & 2032 (%)
    • 8.1.2. Female
    • 8.1.3. Male

9. Cellulite Treatment Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 9.1.2. 18-30 years
    • 9.1.3. 31-45 years
    • 9.1.4. 46-60 years
    • 9.1.5. Above 60 years

10. Cellulite Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Dermatology Clinics
    • 10.1.4. Aesthetic Clinics/Medical Spas
    • 10.1.5. Home Use

11. Cellulite Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cellulite Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cellulite Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cellulite Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cellulite Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cellulite Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cellulite Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc. (Allergan Aesthetics)
    • 12.2.2. Lumenis Ltd.
    • 12.2.3. Candela Medical
    • 12.2.4. Solta Medical
    • 12.2.5. Cynosure LLC
    • 12.2.6. BTL Aesthetics
    • 12.2.7. Cutera Inc.
    • 12.2.8. Merz Pharmaceuticals
    • 12.2.9. Endo International plc
    • 12.2.10. Venus Concept Inc.
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제